Key result
BMSC-derived extracellular vesicles preserve blood-brain barrier integrity and reduce infarct volume better than BEC-EVs.
Answers are grounded in this paper and cite their sources.
Shows extracellular vesicles protect blood-brain barrier integrity in stroke models, indicating a therapeutic role via pathway inhibition.
Background: Ischemic stroke (IS) causes tragic death and disability worldwide. However, effective therapeutic interventions are finite. After IS, blood-brain barrier (BBB) integrity is disrupted, resulting in deteriorating neurological function. As a novel therapeutic, extracellular vesicles (EVs) have shown ideal restorative effects on BBB integrity post-stroke; however, the definite mechanisms remain ambiguous. In the present study, we investigated the curative effects and the mechanisms of EVs derived from bone marrow mesenchymal stem cells and brain endothelial cells (BMSC-EVs and BEC-EVs) on BBB integrity after acute IS. Methods: EVs were isolated from BMSCs and BECs, and we investigated the therapeutic effect in vitro oxygen-glucose deprivation (OGD) insulted BECs model and in vivo rat middle cerebral artery occlusion (MCAo) model. The cell monolayer leakage, tight junction expression, and metalloproteinase (MMP) activity were evaluated, and rat brain infarct volume and neurological function were also analyzed. Results: The administration of two kinds of EVs not only enhanced ZO-1 and Occludin expressions but also reduced the permeability and the activity of MMP-2/9 in OGD-insulted BECs. The amelioration of the cerebral infarction, BBB leakage, neurological function deficits, and the increasing ZO-1 and Occludin levels, as well as MMP activity inhibition was observed in MCAo rats. Additionally, the increased levels of Caveolin-1, CD147, vascular endothelial growth factor receptor 2 (VEGFR2), and vascular endothelial growth factor A (VEGFA) in isolated brain microvessels were downregulated after EVs treatment. In vitro, the employment of Caveolin-1 and CD147 siRNA partly suppressed the expressions of VEGFR2, VEGFA and MMP-2/9 activity and reduced the leakage of OGD insulted BECs and enhanced ZO-1 and Occludin expressions. Conclusion: Our study firstly demonstrates that BEC and BMSC-EVs administrations maintain BBB integrity via the suppression of Caveolin-1/CD147/VEGFR2/MMP pathway after IS, and the efficacy of BMSC-EVs is superior to that of BEC-EVs.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied Acute ischemic stroke. Extracellular vesicles derived from bone marrow mesenchymal stem cells (BMSC-EVs) and brain endothelial cells (BEC-EVs) vs. Untreated OGD-insulted BECs and MCAo rats, and comparison between BMSC-EVs and BEC-EVs was evaluated on Blood-brain barrier integrity, cell monolayer leakage, tight junction (ZO-1, Occludin) expression, MMP-2/9 activity, rat brain infarct volume, and neurological function. BMSC-EV and BEC-EV administration maintained blood-brain barrier integrity and reduced infarct volume in MCAo rats via Caveolin-1/CD147/VEGFR2/MMP-2/9 suppression, with BMSC-EVs superior to BEC-EVs.
Synapse has enriched 10 related papers. Consider them for comparative context: